Sabra Health Care REIT Inc

Análisis de la acción Sabra Health Care REIT Inc (SBRA)

$20.390

-0.218 (-1.07%)Al cierre

Loading chart…
High
20.557
Open
20.530
VWAP
20.40
Vol
1.92M
Mkt Cap
3.50B
Low
20.255
Amount
39.24M
EV/EBITDA, TTM
91.26

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals.

AI analysis of Sabra Health Care REIT Inc (SBRA)

buy

Sabra Health Care REIT Inc is a good buy right now due to its current price of $20.61, which is below the analyst price target of $25, indicating significant upside potential. Additionally, the company has a forward P/E ratio of 32.15, suggesting it is reasonably valued for future earnings growth. The recent announcement of a quarterly dividend of $0.30 reflects stable cash flow and a forward yield of 5.82%, appealing to income-focused investors. However, the main risk is the net loss of $0.10 per share reported in Q2 2026, which may affect investor confidence in the short term.

Analyst Ratings (12)

+2.16% upside
Hold
4 Buy
7 Hold
1 Sell
Current: 20.39
Mínimo
20.00
Promedio
20.83
Máximo
22.00

Mizuho

2026-08-31

Precio objetivo

$21

Neutral

Barclays

2026-08-31

Precio objetivo

$23

Equal Weight

Raymond James

2026-08-06

Precio objetivo

Market Perform

Deutsche Bank

2026-07-22

Precio objetivo

$25

Buy

Baird

2026-07-22

Precio objetivo

$23

Neutral

Métricas de valoración

The current forward P/E ratio for Sabra Health Care REIT Inc (SBRA) is 32.15, compared to its 5-year average forward P/E of 31.48.

Forward P/E

Fair
5Y Average P/E
31.48
Current P/E
32.15
Sobrevalorada
53.85
Infravalorada
9.11

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
14.52
Current EV/EBITDA
91.26
Sobrevalorada
23.69
Infravalorada
5.34

Forward P/S

Fair
5Y Average P/S
5.10
Current P/S
5.19
Sobrevalorada
5.65
Infravalorada
4.54

Alphio AI Price Scenarios for SBRA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SBRA

$19.80

Precio del escenario

B

Base

Base · 50%SBRA

$16.16

Precio del escenario

B

Bear

Bear · 25%SBRA

$13.50

Precio del escenario

Whales holding SBRA

C

CenterSquare Investment Management LLC

+ HoldingSBRA

+3.23%

3M Return

A

Advisors Capital Management, LLC

+ HoldingSBRA

-1.38%

3M Return

SBRA FAQ — answered by Alphio AI

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Sabra Health Care REIT Inc is a good buy right now due to its current price of $20.61, which is below the analyst price target of $25, indicating significant upside potential. Additionally, the company has a forward P/E ratio of 32.15, suggesting it is reasonably valued for future earnings growth. The recent announcement of a quarterly dividend of $0.30 reflects stable cash flow and a forward yield of 5.82%, appealing to income-focused investors. However, the main risk is the net loss of $0.10 per share reported in Q2 2026, which may affect investor confidence in the short term.

12 analysts cover SBRA: 4 rate it Buy, 7 Hold and 1 Sell. The average price target is 20.83.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis